Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans.

Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, Hendrie H.

Neurology. 2000 Jan 11;54(1):240-2.

PMID:
10636159
2.

Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent.

Sahota A, Yang M, Gao S, Hui SL, Baiyewu O, Gureje O, Oluwole S, Ogunniyi A, Hall KS, Hendrie HC.

Ann Neurol. 1997 Oct;42(4):659-61.

PMID:
9382479
3.

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H.

Ann Intern Med. 2002 Aug 6;137(3):149-55.

PMID:
12160362
4.

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA.

Arch Neurol. 2002 Apr;59(4):594-600.

PMID:
11939894
5.

Serum lipoprotein profile and APOE genotype in Alzheimer's disease.

Cagnin A, Zambon A, Zarantonello G, Vianello D, Marchiori M, Mercurio D, Miccichè F, Ermani M, Leon A, Battistin L.

J Neural Transm Suppl. 2007;(72):175-9.

PMID:
17982892
6.

APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.

Tycko B, Lee JH, Ciappa A, Saxena A, Li CM, Feng L, Arriaga A, Stern Y, Lantigua R, Shachter N, Mayeux R.

Arch Neurol. 2004 Sep;61(9):1434-9. Erratum in: Arch Neurol. 2005 Feb;62(2):332.

PMID:
15364690
7.

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.

Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A.

Am J Geriatr Psychiatry. 2006 Dec;14(12):1022-31. Epub 2006 Sep 6.

PMID:
16956959
8.

Influence of APOE genotype on familial aggregation of AD in an urban population.

Devi G, Ottman R, Tang M, Marder K, Stern Y, Tycko B, Mayeux R.

Neurology. 1999 Sep 11;53(4):789-94.

PMID:
10489042
9.

Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease.

Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R.

Ann N Y Acad Sci. 1996 Dec 16;802:6-15.

PMID:
8993479
10.

Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.

Goldstein FC, Ashley AV, Gearing M, Hanfelt J, Penix L, Freedman LJ, Levey AI.

Neurology. 2001 Nov 27;57(10):1923-5.

PMID:
11723294
11.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1977-83.

PMID:
15184600
12.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
13.

Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

Rodríguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O.

J Neurol. 2006 Feb;253(2):181-5. Epub 2005 Aug 17.

PMID:
16096813
14.

Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.

Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Musick B, Class CA, et al.

Ann Neurol. 1995 Jan;37(1):118-20.

PMID:
7818244
15.

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H.

Neurology. 2006 Jan 24;66(2):223-7.

16.

APOE2 and consanguinity: a risky combination for Alzheimer's disease.

Kaur M, Balgir PP.

J Alzheimers Dis. 2005 Dec;8(3):293-7.

PMID:
16340087
17.

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

Romas SN, Tang MX, Berglund L, Mayeux R.

Neurology. 1999 Aug 11;53(3):517-21.

PMID:
10449113
18.

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2005 Oct 11;65(7):1045-50.

PMID:
16217057
19.

Cholesterol and APOE genotype interact to influence Alzheimer disease progression.

Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR.

Neurology. 2004 May 25;62(10):1869-71.

PMID:
15159498
20.

Lipid metabolism in cognitive decline and dementia.

Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V.

Brain Res Rev. 2006 Aug;51(2):275-92. Epub 2006 Jan 10. Review.

PMID:
16410024

Supplemental Content

Support Center